Clinical trial
a Clinical Trial to Evaluate the Efficacy and Safety of Agnucaston Tablets in the Treatment of Premenstrual Syndrome (PMS)
NCT00672607 is registered in ClinicalTrials.gov with Schwabe-Wenex International Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- a Clinical Trial to Evaluate the Efficacy and Safety of Agnucaston Tablets in the Treatment of Premenstrual Syndrome (PMS)
- Lead sponsor
- Schwabe-Wenex International Ltd
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 28, 2005
- Completion date
- January 31, 2007
- Enrollment
- 217 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.